ARDX ARDELYX, INC.
Nasdaq · SEC CIK 1437402 · EDGAR
- Bought, last 12 months
- $1.95M 1 purchases by 1 insiders
- Sold, last 12 months
- $4.30M 38 sales by 9 insiders
- Filings on record
- 324 since 2021-08-05, latest 2026-08-25 19:19
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| RAAB MICHAEL | Pres, CEO, Dir | — | $2.57M |
| MOTT DAVID M | Dir | $1.95M | — |
| Williams Laura A | See Remarks | — | $1.01M |
| Foster Eric Duane | Chief Commercial Off | — | $176.4K |
| Kelliher Mike | See Remarks | — | $162.3K |
| Reilly Joseph James | See Remarks | — | $129.3K |
| Bishop John E | See Remarks | — | $109.2K |
| Brady James Parker | CHRO | — | $84.8K |
| GRAMMER ELIZABETH A | See Remarks | — | $33.2K |
| Hohenleitner Susan | CFO | — | $27.0K |
Transactions 368
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-25 19:19 | 2026-08-21 | ARDX | Hohenleitner Susan | CFO | S - Sale | $3.86 | -1,558 | 227.5K | -0.7% | -$6,009 | |
| M | 2026-08-25 19:17 | 2026-08-21 | ARDX | Reilly Joseph James | See Remarks | S - Sale | $3.86 | -3,982 | 145.9K | -3% | -$15.4K |
| M | 2026-08-25 19:16 | 2026-08-21 | ARDX | Bishop John E | See Remarks | S - Sale | $3.86 | -19.8K | 317.1K | -6% | -$76.2K |
| M | 2026-08-25 19:15 | 2026-08-21 | ARDX | Brady James Parker | CHRO | S - Sale | $3.86 | -15.1K | 245.9K | -6% | -$58.4K |
| M | 2026-08-25 19:13 | 2026-08-21 | ARDX | Foster Eric Duane | Chief Commercial Off | S - Sale | $3.86 | -8,562 | 409.4K | -2% | -$33.0K |
| M | 2026-08-25 19:11 | 2026-08-21 | ARDX | Kelliher Mike | Chief Business Off | S - Sale | $3.86 | -7,758 | 349.7K | -2% | -$29.9K |
| M | 2026-08-25 19:09 | 2026-08-21 | ARDX | Williams Laura A | Chief Patient Off | S - Sale | $3.86 | -10.7K | 367.5K | -3% | -$41.4K |
| M | 2026-08-25 19:07 | 2026-08-21 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $3.86 | -58.6K | 1.62M | -3% | -$225.9K |
| DT | 2026-07-17 16:09 | 2026-07-15 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | M - OptEx | $0.99 | +20.8K | 1.72M | +1% | +$20.6K |
| DT | 2026-07-17 16:09 | 2026-07-15 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale+OE | $5.06 | -41.7K | 1.68M | -2% | -$210.9K |
| DT | 2026-06-22 16:01 | 2026-06-18 | ARDX | Williams Laura A | Chief Patient Off | M - OptEx | $0.99 | +31.0K | 460.1K | +7% | +$30.7K |
| DT | 2026-06-22 16:01 | 2026-06-18 | ARDX | Williams Laura A | Chief Patient Off | S - Sale+OE | $5.99 | -81.9K | 378.2K | -18% | -$490.5K |
| D | 2026-06-18 17:14 | 2026-06-16 | ARDX | Parsey Merdad | Dir | A - Grant | $0.00 | +26.5K | 83.7K | +46% | $0 |
| D | 2026-06-18 16:08 | 2026-06-16 | ARDX | Rodgers Richard J | Dir | A - Grant | $0.00 | +26.5K | 440.0K | +6% | $0 |
| DM | 2026-06-18 16:07 | 2026-06-16 | ARDX | MOTT DAVID M | Dir | A - Grant | $0.00 | +46.7K | 3.35M | +1% | $0 |
| D | 2026-06-18 16:05 | 2026-06-16 | ARDX | Cadoret-Manier Onaiza | Dir | A - Grant | $0.00 | +26.5K | 178.2K | +17% | $0 |
| D | 2026-06-18 16:04 | 2026-06-16 | ARDX | Bhanji Muna | Dir | A - Grant | $0.00 | +26.5K | 163.8K | +19% | $0 |
| DM | 2026-06-18 16:02 | 2026-06-16 | ARDX | Bertrand William C JR | Dir | A - Grant | $0.00 | +38.8K | 329.5K | +13% | $0 |
| D | 2026-06-18 16:01 | 2026-06-16 | ARDX | Bazemore Robert B | Dir | A - Grant | $0.00 | +26.5K | 68.0K | +64% | $0 |
| DT | 2026-06-17 16:01 | 2026-06-15 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | M - OptEx | $0.99 | +20.8K | 1.74M | +1% | +$20.6K |
| DT | 2026-06-17 16:01 | 2026-06-15 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale+OE | $5.67 | -41.7K | 1.70M | -2% | -$236.3K |
| M | 2026-05-22 16:18 | 2026-05-21 | ARDX | Reilly Joseph James | See Remarks | S - Sale | $6.27 | -3,719 | 149.8K | -2% | -$23.3K |
| 2026-05-22 16:17 | 2026-05-21 | ARDX | Hohenleitner Susan | CFO | S - Sale | $6.27 | -1,455 | 229.1K | -0.6% | -$9,119 | |
| 2026-05-22 16:15 | 2026-05-21 | ARDX | Bishop John E | See Remarks | S - Sale | $6.27 | -2,306 | 336.8K | -0.7% | -$14.5K | |
| 2026-05-22 16:14 | 2026-05-21 | ARDX | Brady James Parker | CHRO | S - Sale | $6.27 | -1,846 | 261.1K | -0.7% | -$11.6K | |
| M | 2026-05-22 16:12 | 2026-05-21 | ARDX | Foster Eric Duane | Chief Commercial Off | S - Sale | $6.27 | -7,998 | 418.0K | -2% | -$50.1K |
| M | 2026-05-22 16:10 | 2026-05-21 | ARDX | Kelliher Mike | Chief Business Off | S - Sale | $6.27 | -7,248 | 357.4K | -2% | -$45.4K |
| M | 2026-05-22 16:09 | 2026-05-21 | ARDX | Williams Laura A | Chief Patient Off | S - Sale | $6.27 | -6,989 | 429.1K | -2% | -$43.8K |
| M | 2026-05-22 16:06 | 2026-05-21 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $6.27 | -54.7K | 1.72M | -3% | -$343.1K |
| DT | 2026-05-19 16:03 | 2026-05-15 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | M - OptEx | $0.99 | +20.8K | 1.82M | +1% | +$20.6K |
| DT | 2026-05-19 16:03 | 2026-05-15 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale+OE | $6.28 | -41.7K | 1.77M | -2% | -$261.6K |
| DT | 2026-04-17 16:04 | 2026-04-15 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | M - OptEx | $0.99 | +20.8K | 1.84M | +1% | +$20.6K |
| DT | 2026-04-17 16:04 | 2026-04-15 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale+OE | $6.29 | -41.7K | 1.80M | -2% | -$262.0K |
| D | 2026-03-18 | 2026-03-16 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale+OE | $5.84 | -41.7K | 1.82M | -2% | -$243.3K |
| D | 2026-03-18 | 2026-03-16 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | M - OptEx | $0.99 | +20.8K | 1.86M | +1% | +$20.6K |
| DT | 2026-02-25 | 2026-02-24 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | M - OptEx | $0.99 | +20.8K | 1.88M | +1% | +$20.6K |
| DT | 2026-02-25 | 2026-02-24 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale+OE | $6.26 | -41.7K | 1.84M | -2% | -$260.8K |
| M | 2026-02-23 | 2026-02-20 | ARDX | Brady James Parker | CHRO | S - Sale | $5.85 | -2,543 | 262.9K | -1.0% | -$14.9K |
| M | 2026-02-23 | 2026-02-20 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $5.85 | -46.0K | 1.86M | -2% | -$269.0K |
| M | 2026-02-23 | 2026-02-20 | ARDX | Williams Laura A | See Remarks | S - Sale | $5.85 | -8,176 | 437.1K | -2% | -$47.8K |
| M | 2026-02-23 | 2026-02-20 | ARDX | Bishop John E | See Remarks | S - Sale | $5.85 | -3,179 | 339.2K | -0.9% | -$18.6K |
| M | 2026-02-23 | 2026-02-20 | ARDX | Foster Eric Duane | Chief Commercial Off | S - Sale | $5.85 | -10.4K | 427.2K | -2% | -$61.1K |
| M | 2026-02-23 | 2026-02-20 | ARDX | Reilly Joseph James | See Remarks | S - Sale | $5.85 | -4,991 | 151.8K | -3% | -$29.2K |
| M | 2026-02-23 | 2026-02-20 | ARDX | Kelliher Mike | See Remarks | S - Sale | $5.85 | -9,595 | 364.7K | -3% | -$56.1K |
| 2026-02-23 | 2026-02-20 | ARDX | MOTT DAVID M | Dir | P - Purchase | $5.84 | +333.3K | 3.30M | +11% | +$1.95M | |
| M | 2026-02-23 | 2026-02-20 | ARDX | Hohenleitner Susan | CFO | S - Sale | $5.85 | -2,033 | 230.5K | -0.9% | -$11.9K |
| D | 2026-01-27 | 2026-01-23 | ARDX | Reilly Joseph James | See Remarks | A - Grant | $0.00 | +46.2K | 156.8K | +42% | $0 |
| D | 2026-01-26 | 2026-01-23 | ARDX | Kelliher Mike | See Remarks | A - Grant | $0.00 | +103.1K | 374.3K | +38% | $0 |
| D | 2026-01-26 | 2026-01-23 | ARDX | Foster Eric Duane | Chief Commercial Off | A - Grant | $0.00 | +137.9K | 436.4K | +46% | $0 |
| D | 2026-01-26 | 2026-01-23 | ARDX | Bishop John E | See Remarks | A - Grant | $0.00 | +124.3K | 342.3K | +57% | $0 |
| D | 2026-01-26 | 2026-01-23 | ARDX | Hohenleitner Susan | CFO | A - Grant | $0.00 | +85.7K | 232.6K | +58% | $0 |
| D | 2026-01-26 | 2026-01-23 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | A - Grant | $0.00 | +446.2K | 1.90M | +31% | $0 |
| D | 2026-01-26 | 2026-01-23 | ARDX | Williams Laura A | Chief Patient Off | A - Grant | $0.00 | +82.7K | 444.3K | +23% | $0 |
| D | 2026-01-26 | 2026-01-23 | ARDX | Brady James Parker | CHRO | A - Grant | $0.00 | +99.5K | 265.5K | +60% | $0 |
| D | 2026-01-09 | 2026-01-08 | ARDX | Williams Laura A | Chief Patient Off | S - Sale+OE | $6.98 | -50.0K | 361.6K | -12% | -$349.0K |
| D | 2026-01-09 | 2026-01-08 | ARDX | Williams Laura A | Chief Patient Off | M - OptEx | $0.99 | +50.0K | 409.9K | +14% | +$49.5K |
| 2025-11-25 | 2025-11-21 | ARDX | Reilly Joseph James | See Remarks | S - Sale | $5.54 | -11.1K | 108.9K | -9% | -$61.4K | |
| 2025-11-25 | 2025-11-21 | ARDX | Foster Eric Duane | Chief Commercial Off | S - Sale | $5.54 | -5,814 | 295.7K | -2% | -$32.2K | |
| 2025-11-25 | 2025-11-21 | ARDX | Williams Laura A | Chief Patient Off | S - Sale | $5.54 | -6,426 | 359.9K | -2% | -$35.6K | |
| 2025-11-25 | 2025-11-21 | ARDX | GRAMMER ELIZABETH A | See Remarks | S - Sale | $5.54 | -5,995 | 299.9K | -2% | -$33.2K | |
| 2025-11-25 | 2025-11-21 | ARDX | Kelliher Mike | See Remarks | S - Sale | $5.54 | -5,560 | 271.2K | -2% | -$30.8K | |
| 2025-11-25 | 2025-11-21 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $5.54 | -46.9K | 1.46M | -3% | -$259.8K | |
| 2025-08-28 | 2025-08-21 | ARDX | Kelliher Mike | Chief Business Off | S - Sale | $5.93 | -5,417 | 276.7K | -2% | -$32.1K | |
| DM | 2025-08-28 | 2025-08-26 | ARDX | Williams Laura A | Chief Patient Off | S - Sale+OE | $6.12 | -80.0K | 366.3K | -18% | -$489.6K |
| D | 2025-08-28 | 2025-08-26 | ARDX | Williams Laura A | Chief Patient Off | M - OptEx | $0.99 | +50.0K | 446.3K | +13% | +$49.5K |
| 2025-08-25 | 2025-08-21 | ARDX | Foster Eric Duane | Chief Commercial Off | S - Sale | $5.93 | -15.3K | 301.5K | -5% | -$90.8K | |
| 2025-08-25 | 2025-08-21 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $5.93 | -45.7K | 1.50M | -3% | -$270.9K | |
| 2025-08-25 | 2025-08-21 | ARDX | Renz Justin A | CFO | S - Sale | $5.93 | -7,037 | 409.1K | -2% | -$41.7K | |
| 2025-08-25 | 2025-08-21 | ARDX | GRAMMER ELIZABETH A | See Remarks | S - Sale | $5.93 | -5,841 | 305.9K | -2% | -$34.6K | |
| 2025-08-25 | 2025-08-21 | ARDX | Williams Laura A | Chief Patient Off | S - Sale | $5.93 | -6,261 | 396.3K | -2% | -$37.1K | |
| D | 2025-06-23 | 2025-06-18 | ARDX | Bazemore Robert B | Dir | A - Grant | $0.00 | +41.6K | 41.6K | New | $0 |
| DM | 2025-06-23 | 2025-06-18 | ARDX | MOTT DAVID M | Dir | A - Grant | $0.00 | +72.7K | 2.97M | +3% | $0 |
| 2025-06-23 | 2025-06-18 | ARDX | Parsey Merdad | Dir | A - Grant | $0.00 | +15.2K | 57.3K | +36% | $0 | |
| D | 2025-06-23 | 2025-06-18 | ARDX | Bhanji Muna | Dir | A - Grant | $0.00 | +41.6K | 137.4K | +43% | $0 |
| DM | 2025-06-23 | 2025-06-18 | ARDX | Rodgers Richard J | Dir | A - Grant | $0.00 | +63.0K | 372.0K | +20% | $0 |
| D | 2025-06-23 | 2025-06-18 | ARDX | Cadoret-Manier Onaiza | Dir | A - Grant | $0.00 | +41.6K | 151.7K | +38% | $0 |
| DM | 2025-06-23 | 2025-06-18 | ARDX | Bertrand William C JR | Dir | A - Grant | $0.00 | +60.9K | 290.7K | +27% | $0 |
| 2025-06-18 | 2025-06-16 | ARDX | MOTT DAVID M | Dir | P - Purchase | $3.63 | +200.0K | 2.90M | +7% | +$726.0K | |
| 2025-06-11 | 2025-06-09 | ARDX | MOTT DAVID M | Dir | P - Purchase | $3.69 | +200.0K | 2.70M | +8% | +$738.0K | |
| 2025-05-22 | 2025-05-20 | ARDX | Renz Justin A | CFO | S - Sale | $4.08 | -7,218 | 416.1K | -2% | -$29.4K | |
| 2025-05-22 | 2025-05-20 | ARDX | GRAMMER ELIZABETH A | See Remarks | S - Sale | $4.08 | -5,992 | 311.7K | -2% | -$24.4K | |
| 2025-05-22 | 2025-05-20 | ARDX | Kelliher Mike | See Remarks | S - Sale | $4.08 | -14.5K | 282.2K | -5% | -$59.2K | |
| 2025-05-22 | 2025-05-20 | ARDX | Williams Laura A | Chief Medical Off | S - Sale | $4.08 | -6,421 | 402.6K | -2% | -$26.2K | |
| 2025-05-22 | 2025-05-20 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $4.08 | -46.8K | 1.55M | -3% | -$191.0K | |
| 2025-05-22 | 2025-05-20 | ARDX | Foster Eric Duane | Chief Commercial Off | S - Sale | $4.08 | -2,507 | 316.8K | -0.8% | -$10.2K | |
| 2025-05-19 | 2025-05-15 | ARDX | MOTT DAVID M | Dir | P - Purchase | $3.29 | +100.0K | 2.50M | +4% | +$329.0K | |
| D | 2025-05-14 | 2025-04-28 | ARDX | Parsey Merdad | Dir | A - Grant | $0.00 | +42.1K | 42.1K | New | $0 |
| D | 2025-05-05 | 2025-05-02 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | M - OptEx | $0.99 | +20.8K | 1.64M | +1% | +$20.6K |
| D | 2025-05-05 | 2025-05-02 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale+OE | $4.25 | -41.7K | 1.59M | -3% | -$177.1K |
| 2025-05-05 | 2025-05-02 | ARDX | MOTT DAVID M | Dir | P - Purchase | $4.22 | +381.4K | 2.40M | +19% | +$1.61M | |
| D | 2025-04-08 | 2025-04-04 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale+OE | $4.59 | -41.7K | 1.62M | -3% | -$191.2K |
| D | 2025-04-08 | 2025-04-04 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | M - OptEx | $0.99 | +20.8K | 1.66M | +1% | +$20.6K |
| D | 2025-03-07 | 2025-03-07 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale+OE | $5.36 | -41.7K | 1.64M | -2% | -$223.3K |
| D | 2025-03-07 | 2025-03-07 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | M - OptEx | $0.99 | +20.8K | 1.68M | +1% | +$20.6K |
| D | 2025-02-27 | 2025-02-25 | ARDX | Foster Eric Duane | Chief Commercial Off | A - Grant | $0.00 | +136.7K | 316.7K | +76% | $0 |
| D | 2025-02-27 | 2025-02-25 | ARDX | Williams Laura A | Chief Medical Off | A - Grant | $0.00 | +105.2K | 409.0K | +35% | $0 |
| D | 2025-02-27 | 2025-02-25 | ARDX | Renz Justin A | CFO | A - Grant | $0.00 | +136.7K | 422.6K | +48% | $0 |
| D | 2025-02-27 | 2025-02-25 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | A - Grant | $0.00 | +570.2K | 1.66M | +53% | $0 |
| D | 2025-02-27 | 2025-02-25 | ARDX | GRAMMER ELIZABETH A | See Remarks | A - Grant | $0.00 | +136.7K | 317.7K | +75% | $0 |
| D | 2025-02-27 | 2025-02-25 | ARDX | Kelliher Mike | See Remarks | A - Grant | $0.00 | +136.7K | 296.7K | +85% | $0 |
Purchase Sale Sale after option exercise All abbreviations